伍玮娟

    【摘要】目的：分析孟鲁司特联合舒利迭对支气管哮喘急性发作的临床效果。方法：选取我院2020年1月—2023年1月的120例支气管哮喘急性发作患者，随机将其分成为两组。对照组单用舒利迭，观察组联用孟鲁司特。结果：观察组的有效率明显高于对照组(P<0.05)；治疗前，两组的咳嗽、食欲不振、喘憋和呼吸困难评分无明显差异(P>0.05)，治疗后，两组的咳嗽、食欲不振、喘憋和呼吸困难评分均明显降低(P<0.05)，且观察组的咳嗽、食欲不振、喘憋和呼吸困难评分更低(P<0.05)；治疗前，两组的FEV1/FVC、MVV、MMF和PEF无明显差异(P>0.05)，治疗后，两组的FEV1/FVC、MVV、MMF和PEF均明显改善(P<0.05)，且观察组的FEV1/FVC、MVV、MMF和PEF明显优于对照组(P<0.05)。结论：孟鲁司特联合舒利迭对支气管哮喘急性发作有较好的临床效果。

    【关键词】孟鲁司特；舒利迭；急性发作；支气管哮喘

    Clinical effect of montelukast combined with seretide on acute attack of bronchial asthma

    WU Weijuan

    The First People ’s Hospital of Longxi County， Dingxi， Gansu 748100， China

    【Abstract】Objective：To analyze the clinical effect of montelukast combined with seretide on acute attack of bronchial asthma. Methods：120 patients with acute attack of bronchial asthma in our hospital from January 2020 to January 2023 were randomly divided into two groups. The control group was treated with seretide alone ......